Biomarkers in psychiatry: How close are we?

Frontiers in Psychiatry

Volumn 3, Issue JAN, 2013, Pages

  Kobeissy, Firas ^a   Alawieh, Ali ^b   Mondello, Stefania ^c   Boustany, Rose Mary ^b   Gold, Mark S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; BIPOLAR DISORDER; DISEASE MARKER; DRUG ABUSE; EATING DISORDER; EPIGENETICS; GENOMICS; IMAGE ANALYSIS; LIPIDOMICS; MAJOR DEPRESSION; MEDICAL RESEARCH; MENTAL DISEASE; METABOLOMICS; NEUROPSYCHIATRY; NOTE; PREDICTION; PROTEOMICS; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SYSTEMS BIOLOGY; VALIDITY;

EID: 84877705024     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00114     Document Type: Note

References (18)

1. Alawieh, A., Zaraket, F., Li, J., Mondello, S., Nokkari, A., Razafsha, M., et al. (2012). Systems biology, bioinformatics and biomarkers in neuropsychiatry. Front. Neurosci. 6:187. doi: 10.3389/fnins.2012.00187
2. Avena, N. M. (2011). Food and addiction: implications and relevance to eating disorders and obesity. Curr. Drug Abuse Rev. 4, 131-132.
3. Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89-95.
4. Fang, F. C., and Casadevall, A. (2011). Reductionistic and holistic science. Infect. Immun. 79, 1401-1404.
5. Hayes, R. L., Mondello, S., and Wang, K. (2011). Glial fibrillary acidic protein: a promising biomarker in pediatric brain injury. Pediatr. Crit. Care Med. 12, 603-604.
6. Kobeissy, F. H., Guingab-Cagmat, J. D., Razafsha, M., O'Steen, L., Zhang, Z., Hayes, R. L., et al. (2011). Leveraging biomarker platforms and systems biology for rehabilomics and biologics effectiveness research. PM R 3, S139-S147.
7. Kobeissy,F.H.,Warren,M.W.,Ottens,A.K., Sadasivan, S., Zhang, Z., Gold, M. S., et al. (2008). Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. J. Proteome Res. 7, 1971-1983.
8. Kraemer, H. C., Schultz, S. K., and Arndt, S. (2002). Biomarkers in psychiatry: methodological issues. Am. J. Geriatr. Psychiatry 10, 653-659.
9. Lescuyer, P., Hochstrasser, D., and Rabilloud, T. (2007). How shall we use the proteomics tool-box for biomarker discovery? J. Proteome Res. 6, 3371-3376.
10. Linden, D. E. (2012). The challenges and promise of neuroimaging in psychiatry. Neuron 73, 8-22.
11. Martins-De-Souza, D., Guest, P. C., Vanattou- Saifoudine, N., Harris, L. W., and Bahn, S. (2011). Proteomic technologies for biomarker studies in psychiatry: advances and needs. Int. Rev. Neurobiol. 101, 65-94.
12. Mondello, S., Linnet, A., Buki, A., Robicsek, S., Gabrielli, A., Tepas, J., et al. (2011). Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 70, 666-675.
13. Robeva, R. (2010). Systems biology - old concepts, new science, new challenges. Front. Psychiatry 1:1. doi: 10.3389/fpsyt.2010.00001
14. Schulenborg, T., Schmidt, O., Van Hall, A., Meyer, H. E., Hamacher, M., and Marcus, K. (2006). Proteomics in neurodegeneration-disease driven approaches. J. Neural Transm. 113, 1055-1073.
15. Staner, L. (2006). Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues Clin. Neurosci. 8, 345-352.
16. Tretter, F., and Gebicke-Haerter, P. J. (2012). Systems biology in psychiatric research: from complex data sets over wiring diagrams to computer simulations. Methods Mol. Biol. 829, 567-592.
17. Westerhoff, H. V. (2011). Systems biology left and right. Methods Enzymol. 500, 3-11.
18. Zhang, Z., Larner, S. F., Kobeissy, F., Hayes, R. L., and Wang, K. K. (2010). Systems biology and theranostic approach to drug discovery and development to treat traumatic brain injury. Methods Mol. Biol. 662, 317-329.